The Point of Care Testing Market report lists and studies the leading competitors, as well as provides the insights with strategic industry analysis of the key factors influencing the market dynamics. In this report, the market is segmented according to type, application, end users, and region. Moreover, it presents granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. Each segment and sub-segment is studied carefully to provide a broad segmental analysis of the global Point of Care Testing Market. Such segmental analysis will help clients to focus on high-growth areas of the global market.
Point of Care Testing Market by Product (Glucose testing, HIV testing, Hepatitis C testing, Pregnancy testing), Platform (Microfluidics, Dipstick, Immunoassay), Purchase (OTC, Prescription), Sample (Blood, Urine), End User (Pharmacy, Hospital, Homecare) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America). The Global Point of Care Testing Market size was estimated at USD 39.1 billion in 2023 and is projected to reach USD 78.48 billion in 2030 at a CAGR of 9.1% during the forecast period 2023-2030.
To Understand Business Strategies, Request For a Sample Report at: https://www.delvens.com/get-free-sample/point-of-care-testing-market
Point of Care Testing Market Competitive Landscape:
Abbott (U.S.)
F. Hoffmann-La Roche Ltd (Switzerland)
BD (U.S.)
Siemens Healthcare Private Limited (Germany)
Bio-Rad Laboratories, Inc. (U.S.)
Danaher (U.S.)
Sekisui Diagnostics (U.S.)
Trinity Biotech (Ireland)
bioMérieux (France)
EKF Diagnostics (Germany)
AccuBioTech Co., Ltd. (China)
Instrumentation Laboratory (U.S.)
Beckman Coulter, Inc. (U.S.)
PTS Diagnostics (U.S.)
Nova Biomedical (U.S.)
Chembio Diagnostics, Inc. (U.S.)
Quidel Corporation (U.S.)
Sienco, Inc (U.S.)
Point-of-care testing, often abbreviated as POCT, is a term that refers to medical diagnostic testing conducted in close proximity to the patient. This type of testing is designed to facilitate immediate medical decisions based on the results and ongoing monitoring of the patient's condition. Also known as with-patient testing, POCT is a critical tool in the medical field. It enables healthcare professionals, such as doctors, to obtain accurate, lab-quality diagnostic results in a matter of minutes, as opposed to waiting for hours or even days for results from a traditional laboratory. The primary advantage of point-of-care testing is its ability to expedite patient care. By providing real-time results, it ensures that patients receive the most effective and efficient care possible, right when they need it. This is particularly beneficial in emergency situations or in remote locations where access to a full-scale laboratory may be limited.
Point of Care Testing Market Key Findings:
On the basis of flow assays segment, the swift adoption of Lateral Flow Assay (LFA) testing products in home care environments is a significant trend to note. This rapid uptake is largely due to the convenience and ease of use these products offer, making them an ideal choice for home-based care. Furthermore, market participants are increasingly focusing their efforts on developing innovative LFA-based point of care devices. This focus on innovation is driven by the recognition of the immense potential these devices hold in transforming healthcare delivery. there is a growing understanding of the numerous benefits of lateral flow assay-based point of care tests. These tests are seen as a viable alternative to traditional, time-consuming laboratory procedures. The advantages of LFA-based tests are manifold. They not only save time but also significantly reduce the costs associated with laboratory procedures. This cost-effectiveness is another factor that is expected to drive the popularity of these tests.
On the basis of end user, one of the primary factors contributing to the surge in popularity of home testing kits is their user-friendly nature, which allows for easy operation. Other significant factors include their cost-effectiveness and increased accessibility. Looking ahead, the home care and self-testing sectors are expected to continue their growth trajectory. This is largely due to the efforts of numerous market players and government agencies who are actively forming joint ventures, partnerships, and collaborations. These alliances aim to develop innovative and affordable products that meet the evolving needs of home care.
On the basis of product type, the expectation is that there will be a significant increase in the number of businesses focusing their efforts on the creation and advancement of innovative self-monitoring glucose meters. This is a trend that is likely to stimulate the growth potential of this particular market segment. On the other hand, Roche's Accu-Chek Blood Glucose Monitoring System offers wireless connectivity and app support, allowing users to easily track and manage their glucose levels from their smartphones. These advancements in technology and user-friendly features are expected to contribute significantly to the market growth.
The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America is estimated to account for the largest market share during the forecast period. In North America, Diagnostic testing is considered highly effective by most organizations and verticals.
Point of Care Testing Market Regional Analysis:
North America to Dominate the Market
North America with highest market with increased CAGR in point-of-care testing market with increasing disorder among the population and increased demands for medical diagnostic kits.
Quick detection of the disorder and fast treatment increase the market revenue share of point-of-care test with developed technology with continuous research helps to drive the market.
To Grow Your Business Revenue, Make an Inquiry Before Buying at: https://www.delvens.com/Inquire-before-buying/point-of-care-testing-market
Point of Care Testing Market Recent Developments:
In July 2022, QuantuMDx announced the launch of its new respiratory panel test; Q-POC™ SARS-CoV-2, Flu A/B & RSV Assay.
In July 2022, Boditech Med entered in strategic partnership with Novo Integrated Sciences, Inc. with an aim to expand its biomarker based rapid testing product line across North America.
Point of Care Testing Market Reasons to Acquire:
Increase your understanding of the market for identifying the most suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors.
Gain authentic and granular data access for the Point of Care testing Market to understand the trends and the factors involved in changing market situations.
Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.
In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.
The main content of the Point of Care Testing Market report:
Detailed analysis of the Point of Care Testing Market.
Significant changes have taken place in key aspects of the market.
Detailed market segmentation analysis.
Market analysis of previous, current and forecast periods in terms of value and quantity.
Point of Care Testing Market share analysis.
Evaluation of niche markets.
The main practices of market participants.
The main suggestion is to increase the company’s influence in the market.
Direct Purchase of the Point of Care Testing Market Research Report at: https://www.delvens.com/checkout/point-of-care-testing-market
Browse Related Reports:
Congenital Heart Disease (CHD) Market
Next Generation Sequencing (NGS) Market
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact Us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-8638-5055
